COVID 19 and Bullous Pemphigoid: a hypothesis for a causal link

A. Lucchese, A. Fusco, G. Donnarumma, R. Borgia, A. Baroni, M. Petruzzi

Article ID: 6314
Vol 36, Issue 2S4, 2022
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.202236.2S4.4
Received: 9 May 2022; Accepted: 9 May 2022; Available online: 9 May 2022; Issue release: 9 May 2022

Abstract

Although onset/exacerbation of bullous Pemphigoid (BP) has been reported to occur frequently followingexposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the link, if any, betweenBP dermatoses and the viral infection remains obscure. Therefore, searching for possible molecularmechanisms, we hypothesise that molecular mimicry between BP antigens and the SARS-CoV-2 proteinsmight lead to autoimmune responses cross-reacting with the BP proteins, thus triggering the dermatosispathologies. Using this research paradigm, we analyzed the Bullous Pemphigoid antigen 1 (BP230) andthe SARS-CoV-2 proteome to share minimal immune determinants, i.e., pentapeptides. Results indicate ahigh level of molecular mimicry between BP230 and SARS-CoV-2, thus supporting the hypothesis of crossreactivityas a possible major mechanism in the SARS-CoV-2-associated BP etiopathogenesis.


Keywords

Bullous pemphigoid;BP230;SARS-Cov-2;Covid-19;autoimmunity;molecular mimicry;cross-reactivity


References

Supporting Agencies



Copyright (c) 2022 A. Lucchese, A. Fusco, G. Donnarumma, R. Borgia, A. Baroni, M. Petruzzi




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).